Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

A selective NLRP3 inflammasome inhibitor attenuates behavioral deficits and neuroinflammation in a mouse model of Parkinson's disease
Shuxuan Huang, Zhi Chen, Binglin Fan, et al.
Journal of Neuroimmunology (2021) Vol. 354, pp. 577543-577543
Closed Access | Times Cited: 40

Showing 1-25 of 40 citing articles:

Role of neuroinflammation in neurodegeneration development
Weifeng Zhang, Dan Xiao, Qinwen Mao, et al.
Signal Transduction and Targeted Therapy (2023) Vol. 8, Iss. 1
Open Access | Times Cited: 445
NLRP3 and pyroptosis blockers for treating inflammatory diseases
Rebecca C. Coll, Kate Schroder, Pablo Pelegrı́n
Trends in Pharmacological Sciences (2022) Vol. 43, Iss. 8, pp. 653-668
Open Access | Times Cited: 393
Drugging the NLRP3 inflammasome: from signalling mechanisms to therapeutic targets
Lieselotte Vande Walle, Mohamed Lamkanfi
Nature Reviews Drug Discovery (2023) Vol. 23, Iss. 1, pp. 43-66
Closed Access | Times Cited: 94
Neuroinflammation and Parkinson’s Disease—From Neurodegeneration to Therapeutic Opportunities
Bruna Araújo, Rita Caridade-Silva, Carla Guedes, et al.
Cells (2022) Vol. 11, Iss. 18, pp. 2908-2908
Open Access | Times Cited: 78
Role of α-synuclein in microglia: autophagy and phagocytosis balance neuroinflammation in Parkinson’s disease
Qiankun Lv, Kang‐Xin Tao, Xiaobo Wang, et al.
Inflammation Research (2023) Vol. 72, Iss. 3, pp. 443-462
Closed Access | Times Cited: 45
Inflammasomes in neurological disorders — mechanisms and therapeutic potential
Kishore Aravind Ravichandran, Michael T. Heneka
Nature Reviews Neurology (2024) Vol. 20, Iss. 2, pp. 67-83
Closed Access | Times Cited: 33
Innate immune activation in neurodegenerative diseases
Sergio Castro‐Gomez, Michael T. Heneka
Immunity (2024) Vol. 57, Iss. 4, pp. 790-814
Closed Access | Times Cited: 14
NLRP3 Inflammasome-Mediated Neuroinflammation and Related Mitochondrial Impairment in Parkinson’s Disease
Qiu-Qin Han, Weidong Le
Neuroscience Bulletin (2023) Vol. 39, Iss. 5, pp. 832-844
Open Access | Times Cited: 32
Inflammasome inhibition protects dopaminergic neurons from α-synuclein pathology in a model of progressive Parkinson’s disease
Alexander Grotemeyer, Judith F. Fischer, James B. Koprich, et al.
Journal of Neuroinflammation (2023) Vol. 20, Iss. 1
Open Access | Times Cited: 18
The central role of the NLRP3 inflammasome pathway in the pathogenesis of age-related diseases in the eye and the brain
Jack Jonathan Maran, Moradeke M. Adesina, Colin Green, et al.
Ageing Research Reviews (2023) Vol. 88, pp. 101954-101954
Closed Access | Times Cited: 18
GSDMD in peripheral myeloid cells regulates microglial immune training and neuroinflammation in Parkinson's disease
Bingwei Wang, Yan Ma, Sheng Li, et al.
Acta Pharmaceutica Sinica B (2023) Vol. 13, Iss. 6, pp. 2663-2679
Open Access | Times Cited: 17
Potential convergence of olfactory dysfunction in Parkinson’s disease and COVID-19: The role of neuroinflammation
Hui Li, Junliang Qian, Youcui Wang, et al.
Ageing Research Reviews (2024) Vol. 97, pp. 102288-102288
Closed Access | Times Cited: 6
Inactivation of NLRP3 inflammasome by dephosphorylation at Serine 658 alleviates glial inflammation in the mouse model of Parkinson’s disease
Rongxin Zhu, Ren-Wen Han, Yue-Han Chen, et al.
Molecular Neurodegeneration (2025) Vol. 20, Iss. 1
Open Access
Inflammasome Activation in Parkinson’s Disease
Shannon Jewell, Ashane M. Herath, Richard D. Gordon
Journal of Parkinson s Disease (2022) Vol. 12, Iss. s1, pp. S113-S128
Open Access | Times Cited: 26
Interaction between autophagy and the NLRP3 inflammasome in Alzheimer’s and Parkinson’s disease
Ranran Lu, Lijie Zhang, Xinling Yang
Frontiers in Aging Neuroscience (2022) Vol. 14
Open Access | Times Cited: 26
Levodopa Improves Behavioral Deficits of Mice with Parkinson's Disease Symptoms via Curbing NLRP3 Inflammasome Activation and Enhancing Tyrosine Hydroxylase Levels in the Striatum and Substantia Nigra
Xi Chen, Zhao Wang, Weihua Yang, et al.
Journal of Integrative Neuroscience (2024) Vol. 23, Iss. 1, pp. 2-2
Open Access | Times Cited: 4
Inflammasome activation in neurodegenerative diseases
Kishore Aravind Ravichandran, Michael T. Heneka
Essays in Biochemistry (2021) Vol. 65, Iss. 7, pp. 885-904
Open Access | Times Cited: 28
Targeting NLRP3 Inflammasomes: A Trojan Horse Strategy for Intervention in Neurological Disorders
Mohammad Amin Bayat Tork, Soroush Fotouhi, Parvin Roozi, et al.
Molecular Neurobiology (2024)
Closed Access | Times Cited: 3
The emerging roles of absent in melanoma 2 (AIM2) inflammasome in central nervous system disorders
Yu-Ke Li, Jianguo Chen, Fang Wang
Neurochemistry International (2021) Vol. 149, pp. 105122-105122
Closed Access | Times Cited: 24
Oridonin relieves depressive‐like behaviors by inhibiting neuroinflammation and autophagy impairment in rats subjected to chronic unpredictable mild stress
Liang Liang, Hui Wang, Ying Hu, et al.
Phytotherapy Research (2022) Vol. 36, Iss. 8, pp. 3335-3351
Open Access | Times Cited: 15
Targeting the inflammasome in Parkinson’s disease
Qi Su, Wei Lun Ng, Suh Yee Goh, et al.
Frontiers in Aging Neuroscience (2022) Vol. 14
Open Access | Times Cited: 15
NLRP3 inflammasome regulates astrocyte transformation in brain injury induced by chronic intermittent hypoxia
Ningning She, Yewen Shi, Yani Feng, et al.
BMC Neuroscience (2022) Vol. 23, Iss. 1
Open Access | Times Cited: 15
Probiotic Formulation VSL#3 Interacts with Mesenchymal Stromal Cells To Protect Dopaminergic Neurons via Centrally and Peripherally Suppressing NOD-Like Receptor Protein 3 Inflammasome-Mediated Inflammation in Parkinson’s Disease Mice
Liping Zhou, Deqiang Han, Xingzhe Wang, et al.
Microbiology Spectrum (2023) Vol. 11, Iss. 2
Open Access | Times Cited: 8
Safranal exerts a neuroprotective effect on Parkinson’s disease with suppression of NLRP3 inflammation activation
Wenping Yang, Yongyue Wei, Jin Sun, et al.
Molecular Biology Reports (2024) Vol. 51, Iss. 1
Open Access | Times Cited: 2
The roles of AIM2 in neurodegenerative diseases: insights and therapeutic implications
Kai Yang, Xi Wang, Hanyu Pan, et al.
Frontiers in Immunology (2024) Vol. 15
Open Access | Times Cited: 2
Page 1 - Next Page

Scroll to top